Just when you thought it was safe to buy essential medicines, “pharma bro” Martin Shkreli is back. This time he’s CEO of KaloBios Pharmaceuticals, which has announced plans to apply next year for FDA approval for benznidazole, used to treat Chagas disease. Shkreli and his…

As the global leader in the manufacture and export of generic drugs, could India help Africa improve access to lifesaving meds? India's prime minister Narendra Modi met recently with leaders of more than 50 African countries to explore the possibility. But some factories…

The recent news that antivenom manufacturer Sanofi-Pasteur is leaving the sub-Saharan African market sparked new and welcome attention on snake bites.

At last night's debate, the 5 US Democratic party presidential candidates named their top enemies, the BBC reported; their answers reinforce the importance of 2 key public health issues in the race:

The world's 20 top-selling medicines cost, on average, 3 times more in the US than in Britain, 6 times more in the US than Brazil and 16 times more in the US than in the lowest priced country (usually India), according to a new Reuters analysis. The 20 medicines together…

A dozen Pacific Basin countries signed a free-trade agreement yesterday, the Trans-Pacific Partnership (see the New York Times coverage). Governments need to ratify the deal individually, though, and it’s not expected to be an easy fight.

US pressure on India to change its intellectual property policies could result in millions of people around the world losing their lifeline to affordable medicines, warns Médecins Sans Frontières (MSF). MSF relies on affordable generic medicines produced in India to do its…

At some point over the course of this massive 15-chapter Huffington Post docu-serial, you will get angry, the editors warn. If you haven’t started reading the series yet (it’s on chapter 11 of 15), it’s a decades-long story of the strategies and tactics Johnson &…

When Turing Pharmaceuticals CEO Martin Shkreli jacked up the price of the malaria and toxoplasmosis drug Daraprim from $13.50 to $750 per pill (see The New York Times story), he may have unintentionally bolstered the case to boost public funding for pharmaceutical research.

Feeling foggy or a little slow? Maybe modafinil can help. The drug, typically used to treat sleep disorders, does double duty as a cognitive enhancer, improving decision-making, planning and other complex thinking processes, reports a new study in European…